Jack brings with him over a decade of experience in drug discovery across multiple disciplines including medicinal chemistry, analytical chemistry, DMPK and metabolite identification. This combination of experience has equipped him well in helping to drive the expansion of the Extractables & Leachables expertise at 91´ÎÔª Manchester.
Industry Experience
Prior to joining 91´ÎÔª, Jack had over 10 years experience in drug discovery and pharmacokinetics. Jack began his Extractables & Leachables journey as a Study Director when he joined the team at Hall (now 91´ÎÔª Manchester) in 2018. Since then, Jack has applied his strong technical background to grow the scientific capacity and capability of the Extractables & Leachables teams now driving 91´ÎÔª Manchester’s medical devices testing services.
As Section Head – Technical, Jack now has responsibility for study oversight, data specialists and development scientists working together to deliver high quality Extractables & Leachables studies to support client submissions.
Career Highlights
Created and expanded the Study Director, R&D and Data Specialist teams at 91´ÎÔª Manchester
Directed a series of studies over two years to support a successful FDA application of a novel risk reduction product
Synthesised drug candidates that have progressed to Phase II clinical trials
Developed a bespoke automated process for performing large scale plate synthesis in support of the European Lead Factory
91´ÎÔª has one of the largest and most experienced extractables and leachables (E&L) practices in the world.
Backed by regulatory expertise, extensive experience, and a vast extractables database, our comprehensive E&L solutions ensure the safety of materials used across the healthcare sector.
We deliver tailored studies for pharmaceutical, biologic, medical device, reduced risk, combination products and more, in accordance with regulatory expectations.
